-
(1S,2S,4S,5S,7R,8R,9S,11S)-8-hydroxy-1-methyl-7-(propan-2-yl)-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one
-
ChemBase ID:
133318
-
Molecular Formular:
C20H24O6
-
Molecular Mass:
360.40096
-
Monoisotopic Mass:
360.15728849
-
SMILES and InChIs
SMILES:
CC(C)[C@@]12[C@@H](O1)[C@H]1[C@@]3(O1)[C@]1(CCC4=C(C1C[C@H]1[C@]3([C@@H]2O)O1)COC4=O)C
Canonical SMILES:
O=C1OCC2=C1CC[C@]1(C2C[C@H]2[C@@]3([C@@]41O[C@H]4[C@@H]1O[C@@]1([C@H]3O)C(C)C)O2)C
InChI:
InChI=1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11?,12-,13-,14-,16+,17-,18-,19+,20+/m0/s1
InChIKey:
DFBIRQPKNDILPW-KTGKZQHOSA-N
-
Cite this record
CBID:133318 http://www.chembase.cn/molecule-133318.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1S,2S,4S,5S,7R,8R,9S,11S)-8-hydroxy-1-methyl-7-(propan-2-yl)-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one
|
|
|
IUPAC Traditional name
|
(1S,2S,4S,5S,7R,8R,9S,11S)-8-hydroxy-7-isopropyl-1-methyl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one
|
|
|
Synonyms
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.649559
|
H Acceptors
|
5
|
H Donor
|
1
|
LogD (pH = 5.5)
|
1.3276725
|
LogD (pH = 7.4)
|
1.3276701
|
Log P
|
1.3276726
|
Molar Refractivity
|
87.2606 cm3
|
Polarizability
|
35.78344 Å3
|
Polar Surface Area
|
84.12 Å2
|
Rotatable Bonds
|
1
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
T3652
|
Biochem/physiol Actions Triptolide is a diterpene triepoxide, the principal active ingredient in extracts from the Chinese herb Tripterygium wilfordii hook (TwHF). It is a potent immunosuppressant and anti-inflammatory. Triptolide has been shown to inhibit the expression of IL-2 in activated T cells at the level of purine-box/nuclear factor and NF-κB mediated transcription activation. It synergizes with cyclosporin A in promoting graft survival in animal models and in suppression of graft versus host disease in allogeneic bone marrow transplants. In addition, it induces apoptosis in tumor cells and potentiates tumor necrosis factor (TNFα) induction of apoptosis in part through the suppression of c-IAP2 and c-IAP1 induction. |
PATENTS
PATENTS
PubChem Patent
Google Patent